These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 32602002)
21. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma. Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935 [TBL] [Abstract][Full Text] [Related]
22. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients. Abdulla M; Laszlo S; Triumf J; Hedström G; Berglund M; Enblad G; Amini RM Acta Oncol; 2016; 55(9-10):1126-1131. PubMed ID: 27549735 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma. Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011 [TBL] [Abstract][Full Text] [Related]
24. [Factors affecting the prognosis of diffuse large B-cell lymphoma in Chinese]. Weng Y; Gao ZF; Liu K; Zhang WJ; Ke XY; Li M Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):681-3. PubMed ID: 16202261 [TBL] [Abstract][Full Text] [Related]
25. p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function. Xu-Monette ZY; Zhang S; Li X; Manyam GC; Wang XX; Xia Y; Visco C; Tzankov A; Zhang L; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Young KH Aging (Albany NY); 2016 Feb; 8(2):345-65. PubMed ID: 26878872 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of MIB-1 and p53 overexpression as risk factors in large cell non-Hodgkin lymphoma in adults. El-Bolkainy TN; El-Bolkainy MN; Khaled HM; Mokhtar NM; Eissa SS; Gouda HM; El-Hattab OH J Egypt Natl Canc Inst; 2007 Dec; 19(4):231-8. PubMed ID: 19672286 [TBL] [Abstract][Full Text] [Related]
27. Clinical features of testicular lymphoma. Shih HJ; Shih LY; Chang H; Wang PN; Wu JH; Kuo MC; Hung YS; Dunn P Acta Haematol; 2014; 131(3):187-92. PubMed ID: 24247653 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma. Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965 [TBL] [Abstract][Full Text] [Related]
30. PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma. Liu YY; Yao SN; Zhao Y; Yao ZH; Ma J; Xia QX; Fu K; Yang SJ Leuk Lymphoma; 2010 Sep; 51(9):1692-8. PubMed ID: 20807096 [TBL] [Abstract][Full Text] [Related]
31. Primary diffuse large B-cell lymphoma of the testis. Horne MJ; Adeniran AJ Arch Pathol Lab Med; 2011 Oct; 135(10):1363-7. PubMed ID: 21970494 [TBL] [Abstract][Full Text] [Related]
33. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome. Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200 [TBL] [Abstract][Full Text] [Related]
34. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era. Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical investigation of P16, P53 and Ki-67's prognostic values in diffuse large B-Cell lymphomas. Baran M; Canoz O; Altuntas H; Sivgin S; Cetin M; Yay A; Ketenci S Bratisl Lek Listy; 2017; 118(10):602-608. PubMed ID: 29198127 [TBL] [Abstract][Full Text] [Related]
36. High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses. Oishi N; Kondo T; Nakazawa T; Mochizuki K; Tanioka F; Oyama T; Yamamoto T; Iizuka J; Tanabe K; Shibata N; Kirito K; Katoh R Pathol Int; 2015 Oct; 65(10):528-35. PubMed ID: 26388135 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma. Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513 [TBL] [Abstract][Full Text] [Related]
38. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas. Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524 [TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase positive large B-cell lymphoma: Literature review and report of an endoscopic fine needle aspiration case with tigroid backgrounds mimicking seminoma. Sakr H; Cruise M; Chahal P; Cotta C; Cook J; Chalikonda S; Rosenblatt S; Hamadeh F; Al-Nourhji O; Sturgis CD Diagn Cytopathol; 2017 Feb; 45(2):148-155. PubMed ID: 27686567 [TBL] [Abstract][Full Text] [Related]
40. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma. Andhavarapu S; Crozier JA; Jiang L; Sher T Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]